← Leaderboards
Laura Beres
Johns Hopkins University
$852,443
Attributed
$852,443
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $213.9K · FY2016–25$250K$187.5K$125K$62.5K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$852,443 · 2
By mechanism
K01$695,672 · 1
F31$156,771 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Elizabeth Marion Jaffee$29,780,612
- William George Nelson$34,555,726
- Charles W. Flexner$41,000,447
- Peter A Merkel$19,482,229
- Michael A. Carducci$23,642,506
Others in their field
Top investigators on “Data Collection”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$578,168,859
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$414,261,438
- David Heimbrook · Leidos Biomedical Research, Inc.$318,215,888
- Marian Ewell · The Emmes Company, Llc$276,352,498
Research focus
Data CollectionAids PreventionInnovationSkillsResearch PersonnelInternationalZambiaAfrica South Of The SaharaTrainingSamplingCharacteristicsEffectivenessEnsureHealth Care FacilityInfectious Diseases ResearchEvidence BaseAdolescent And Young AdultExperimental StudyAffectiveCognitiveCompetenceFormulationAreaEducational Status
Grant awards (10)
Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia$137,570
K01 · FY2025 · MH · contact PI
Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia$19,781
K01 · FY2025 · MH · contact PI
Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia$160,061
K01 · FY2024 · MH · contact PI
Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia$53,822
K01 · FY2024 · MH · contact PI
Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia$161,186
K01 · FY2023 · MH · contact PI
Optimizing implementation of long-acting, injectable Cabotegravir for HIV prevention among adolescents and young adults in Zambia$163,252
K01 · FY2022 · MH · contact PI
Patterns and Factors Influencing Return to Care among HIV Patients in Zambia$24,627
F31 · FY2019 · MH · contact PI
Patterns and Factors Influencing Return to Care among HIV Patients in Zambia$44,524
F31 · FY2018 · MH · contact PI
Patterns and Factors Influencing Return to Care among HIV Patients in Zambia$44,044
F31 · FY2017 · MH · contact PI
Patterns and Factors Influencing Return to Care among HIV Patients in Zambia$43,576
F31 · FY2016 · MH · contact PI